Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Elasmogen and Feldan announce research collaboration with Amgen

May 9, 2017

Board recommends continuation of Fibrocell Science's phase I/II study of FCX-007

May 9, 2017

Durect enters Posimir development and commercialization agreement with Sandoz

May 9, 2017

Regeneron enters agreements with Inovio and SillaJen for combination studies of REGN-2810

May 9, 2017

Seattle Genetics and Immunomedics terminate license agreement for sacituzumab govitecan

May 9, 2017

Immunocore identifies new ImmTAC lead molecule under collaboration with GSK

May 8, 2017

Commense signs licensing agreement with UBC for microbiome-based therapy to prevent asthma

May 5, 2017

MDxHealth and Maastricht University expand research collaboration

May 5, 2017

Saniona participates in formation of Scandion Oncology

May 5, 2017

NIH grant supports Spero's preclinical development of SPR-720 for TB

May 5, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 8, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.